Health Discovery Corporation
Health Discovery Corporation Announces Successful Phase II Clinical Trial Results for New Gene-Based Molecular Diagnostic Test for Prostate Cancer
Published in Medical Device Law Weekly, July 20th, 2008
Health Discovery Corporation ("HDC") (OTCBB: HDVY) announced the successful phase II clinical trial results for HDC's new gene-based molecular diagnostic test for prostate cancer licensed exclusively to Clarient (Nasdaq: CLRT), in which HDC will receive a 30 percent royalty on each test performed based on the per test reimbursement received by Clarient. In addition to the commercialization license HDC granted to Clarient, HDC retained the right to also commercialize this molecular diagnostic test for prostate cancer in one or more clinical laboratories that HDC elects to own and/or operate.
Results from both the Phase I and Phase II clinical validation studies now...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Law Weekly
More Articles from Medical Device Law Weekly
- Autopsy
Data from University of Hamburg advance knowledge in autopsy - Hearing Loss
Task Force Recommends Screening for Hearing Loss in All Newborns - Heart Attack
Back From the Dead: Cardiac Arrest Victim Salutes His Rescuer - Merck & Co., Inc.
Merck & Co., Inc Receives Complete Response Letter from the Food and Drug Administration for Use of GARDASIL in Women Ages 27 through 45 - Abbott
FDA Approves Abbott's XIENCE V Drug Eluting Stent - Abdominal Aortic Aneurysm Therapy
Research from University of California, Division of Cardiovascular Medicine in the area of abdominal aortic aneurysm therapy published - More from this issue of Medical Device Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
